Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: ACE2

March 3, 2023 CD as API / Pharma applications

Veklury® (remdesivir) formulations inhibit initial membrane-coupled events of SARS-CoV-2 infection due to their sulfobutylether-β-cyclodextrin content

Background and purpose: Despite its contradictory clinical performance, Veklury® (remdesivir) has a pivotal role in COVID-19 therapy. Possible contributions of the

Continue reading

April 29, 2021 CD as API / Drug delivery / Pharma applications

Targeting Lipid Rafts as a Strategy Against Coronavirus

Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol. These regions are characterized by highly ordered and

Continue reading

March 12, 2021 Drug delivery / Pharma applications

An interesting hypothesis: CD‐sACE2 inclusion compounds to treat COVID‐19

Angiotensin‐converting enzyme 2 (ACE2) has been identified as the main receptors for SARS‐CoV and SARS‐CoV‐2. Soluble ACE2 (sACE2) can bind

Continue reading

October 17, 2020 Drug delivery

COVID-19 is Less Frequent at High Altitude Under Hypobaric conditions: The South-American Experience

As a cyclodextrin (SBECD) is used in one of the most potent drug formulation against Covid-19 the readers of the

Continue reading

July 17, 2020 Drug delivery / Pharma applications

CD‐sACE2 complexes against Covid-19

Cyclodextrin‐soluble angiotensin‐converting enzyme 2 (CD‐sACE2) inclusion compounds can be useful in the treatment of SARS‐CoV‐2 infections by blocking S‐proteins .

Continue reading

Recent Posts

  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • Bezhan Chankvetadze: The power of weak non-covalent interactions in molecular recognition
  • Pressurized hot water to improve complexation
  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • A Cyclodextrin Surprise in a Japanese Supplement

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (68)
  • CD as API (347)
  • CD derivatives (411)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (794)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (224)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (402)
  • Other industrial use (107)
  • Pharma applications (1,186)
  • Supramolecular systems (40)
  • Uncategorized (151)

Top Posts

  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Pressurized hot water to improve complexation
  • Bezhan Chankvetadze: The power of weak non-covalent interactions in molecular recognition
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Does Vinblastine Retain its Anticancer Effect in the Presence of Cyclodextrin? A Preliminary Study
  • A Mix of β-Cyclodextrin and Lactic Acid for Greener Aroma Solutions
  • Is CD shuttle or sink for cholesterol?
  • Ipecon®: a novel betadex sulfobutylether sodium containing veterinary drug composition

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...